InvestorsHub Logo
Followers 112
Posts 4708
Boards Moderated 0
Alias Born 02/20/2012

Re: 1center post# 274820

Monday, 11/27/2017 12:02:14 PM

Monday, November 27, 2017 12:02:14 PM

Post# of 275587
$SPRWF 1.58 Supreme Pharmaceutical News Friday 11/24/17 #cannabis

SUPREME SIGNS HIGH-QUALITY FLOWER SUPPLY LOI AGREEMENT WITH ABLE BC.
http://www.supreme.ca/news/press-release-details/2017/Supreme-signs-High-Quality-Flower-supply-LOI-agreement-with-ABLE-BC/default.aspx

The Alliance of Beverage Licensees (ABLE BC)
https://ablebc.ca

B.C.’s liquor stores are the responsible way to retail #cannabis $SPRWF
http://vancouversun.com/opinion/op-ed/opinion-b-c-s-liquor-stores-are-the-responsible-way-to-retail-cannabis


Website: Supreme Pharmaceuticals
http://www.supreme.ca/investors/overview/default.aspx

Filings: on Sedar
http://sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00006000

https://twitter.com/supremepharma


Supreme Pharmaceuticals Inc—Producing Craft Quality Cannabis at Commercial Scale

Overview

Supreme Pharmaceuticals Inc (TSXV:FIRE) is a licensed producer uniquely implementing B2B cannabis sales within Canada. Based in Ontario, the company is headed in Toronto and their sole asset, 7ACRES, is situated in Kincardine, on the southern shores of Lake Huron. Supreme Pharmaceuticals’ mission is to lead the cannabis industry, innovate and keep pushing cannabis forward while remaining focused on the quality of the product.

The first to adopt a licensed B2B wholesale model in Canada, Supreme Pharmaceuticals’ approach is based on producing high-quality cannabis that can be sold at a commercial scale to licensed producers, value-add manufacturers, storefronts and more. The goal of this approach is to allow for specialization across the industry, allowing partners to develop and succeed while they are supplied with quality cannabis.

To this effect, once they obtained their license to sell from their 7ACRES property in June 2017, Supreme Pharmaceutical entered into sale partnerships in September with two licensed producers, Aurora Cannabis (TSXV:ACB) and Emerald Health Botanicals, a subsidiary of Emerald Health Therapeutics (TSXV:EMH).

The 7ACRES property is on its way to becoming the country’s leading producer of high-quality commercial cannabis at a scale that has not yet been seen. Currently cultivating on 16,500 square feet, Supreme expects to have the entire 342,000-square-foot hybrid greenhouse facility running at full capacity by 2019 with a projected 50,000 kilograms of cannabis produced per year and $200 million to $400 million in revenue per year.

Supreme’s management team is one with vast amounts of experience in the cannabis and financial sectors. The team is headed by John Fowler, a lawyer that has been an advocate for the cannabis industry and thus has deep knowledge of both the medicinal and recreational spaces.

Investment Highlights

Innovative wholesale business model for bulk cannabis sales to strategic partners
Low operational costs to produce high-quality product
License to sell received in June 2017
Partnerships for cannabis sales with Aurora Cannabis and Emerald Health Botanicals
First reported quarter of sales to be reported by end of 2017
Well-funded with over $70 million raised collectively in 2016 and 2017
2016 private placement of $55 million from a syndicate of four banks led by Canaccord Genuity Corp
7ACRES property with 342,000 square-foot hybrid greenhouse facility
Expecting to run at full capacity in 2019 producing 50,000 kg per annum
Strong management team with notable experience in the cannabis space
More
https://investingnews.com/company-profiles/cannabis-wholesale-commercial-scale-producing-craft-quality-7acres/

1c

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.